EW

Edwards Lifesciences Corp
80.76
1.21 (1.52%)

Edwards Lifesciences Corporation (EW) Fundamentals

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery.
SHARE INFORMATION
Market Cap$ 48,306,166,776
Shares Outstanding608,313,396
Float603,493,882
Percent Float99.21%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 5,382,400,000
Latest Fiscal EPS$ 2.44
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashStock
HOLDERS
Institutions2,567
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months54,552,580
Institutional Holdings Percent150.5%
Institutional Sold Previous 3 Months83,405,527
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months139,915
Insider Holdings Percent0.3
Insider Sold Previous 3 Months236,758
Insider Shares Owned1,734,389
TRADING INFO
52 Week High$ 131.10
52 Week Low$ 67.13
52 Week High Change$ -29.69
21 Day Moving Average$ 78.7414
21 Day Extended Moving Average$ 79.071
50 Day Moving Average$ 78.5304
50 Day Extended Moving Average$ 78.4189
200 Day Moving Average$ 84.9441
200 Day Extended Moving Average$ 84.8155
10 Day Average Volume4,531,413
20 Day Average Volume4,127,527
30 Day Average Volume3,813,306
50 Day Average Volume3,732,860
Alpha0.005997
Beta1.0055
Standard Deviation0.090289
R20.359677
7 Day Price Change$ -0.07
7 Day Percent Change-0.09%
21 Day Price Change$ -0.43999
21 Day Percent Change-0.55%
30 Day Price Change$ 3.98
30 Day Percent Change5.28%
Month to Date Price Change$ -1.03
Month to Date Percent Change-1.28%
Quarter to Date Price Change$ 4.80
Quarter to Date Percent Change6.43%
180 Day Price Change$ -4.76
180 Day Percent Change-5.66%
200 Day Price Change$ -9.28
200 Day Percent Change-10.46%
Year to Date Price Change$ 4.80
Year to Date Percent Change6.43%

Edwards Lifesciences Corporation (EW) Key Ratios

PROFITABILITY
EBIT Margin34.3%
EBITDA Margin36.8%
Pre-Tax Profit Margin27.7%
Profit Margin Count28.26%
Gross Margin79.9%
Profit Margin TOT28.26%
INCOME STATEMENTS
Revenue$ 5,382,400,000
Revenue Per Share$ 8.8804
Revenue (3 Years)$ 8.51
Revenue (5 Years)$ 9.81
FINANCIAL STRENGTH
Price to Tangible Book11.40
Total Debt To Equity0.10
Int Coverage93.10
Current Ratio3.00
Leverage Ratio1.40
Quick Ratio1.90
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio33.50
Enterprise Value$ 49,193,453,855
Price to Sales8.9422
Price to Free Cash53.30
PE High Last 5 Years102.10
Price To Book8.60
Price To Cash Flow41.90
PE Low Last 5 Years28.10
Price to Tangible Book11.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.70
Invoice Turnover1.40
Assets Turnover0.60
Return Assets18.66
Return on Equity26.91
Return on Capital22.22

Edwards Lifesciences Corporation (EW) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOMichael A. Mussallem
Emplyoees17300
Last AuditUQ
CIK0001099800
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical Appliance and Supplies Manufacturing(339113)
CONTACT INFO
AddressOne Edwards Way
Irvine, CA 92614
Websitehttps://www.edwards.com
Facsimile+1 949 250-2525
Telephone+1 949 250-2500
Emailinvestor_relations@edwards.com


Your Recent History
NYSE
EW
Edwards Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.